Millipore Sigma Vibrant Logo

324380 Doxorubicin, Hydrochloride - CAS 25316-40-9 - Calbiochem

Doxorubicin HCl, CAS 25316-40-9, is an antitumor antibiotic that inhibits topoisomerase II (IC₅₀ = 100 nM).

SDB (Sicherheitsdatenblätter), Analysenzertifikate und Qualitätszertifikate, Dossiers, Broschüren und andere verfügbare Dokumente.

Synonyme: Adriamycin, 14-Hydroxydaunomycin, HCl

Primary Target: topoisomerase 2
View Products on Sigmaaldrich.com
324380
  
Preis wird abgerufen...
Preis nicht abrufbar
Die Mindestmenge muss ein Vielfaches sein von
Maximum Quantity is
Bei Bestätigung Weitere Informationen
Sie haben () gespart
 
—
Bitte erfragen
—
Eingeschränkte Verfügbarkeit Eingeschränkte Verfügbarkeit
Lieferbar 
Produkt wurde eingestellt
Begrenzter Lagerbestand
Bestätigung der Verfügbarkeit erforderlich
    Restmenge: Angebot folgt
      Restmenge: Angebot folgt
      Bitte erfragen
      Kontakt zum Kundenservice
      Contact Customer Service

       

      Kontakt zum Kundenservice

      Übersicht

      Replacement Information

      Key Spec Table

      CAS #Empirical Formula
      25316-40-9C₂₇H₂₉NO₁₁ · HCl
      Description
      OverviewAntitumor antibiotic and a highly effective myotoxin that inhibits topoisomerase II (IC50 = 100 nM). Binds to nucleic acids, presumably by specific intercalation into the DNA double helix, thereby inhibiting nucleic acid synthesis. Induces apoptosis in rhabdomyosarcoma cell lines. Also available as a 10 mM solution in H2O (Cat. No. 504042).
      Catalogue Number324380
      Brand Family Calbiochem®
      SynonymsAdriamycin, 14-Hydroxydaunomycin, HCl
      References
      ReferencesA'Hern, R.P., and Gore, M.E. 1995. J. Clin. Oncol. 13, 726.
      Nooter, K., et al. 1995. Br. J. Cancer 71, 556.
      Noviello, E., et al. 1994. Mutat. Res. 311, 21.
      Anderson, R.D., et al. 1993. Mutat. Res. 294, 215.
      Hershko, C., et al. 1993. J. Lab. Clin. Med. 122, 245.
      Jongmans, W., et al. 1993. Mutat. Res. 294, 207.
      O'Shaughnessy, J.A., and Cowan, K.H. 1993. J. Am. Med. Assoc. 270, 2089.
      Theyer, G., et al. 1993. J. Urol. 150, 1544.
      Tritton, T.R., and Yee, G. 1982. Science 217, 248.
      Product Information
      CAS number25316-40-9
      ATP CompetitiveN
      FormOrange to red powder
      Hill FormulaC₂₇H₂₉NO₁₁ · HCl
      Chemical formulaC₂₇H₂₉NO₁₁ · HCl
      Hygroscopic Hygroscopic
      ReversibleN
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Primary Targettopoisomerase 2
      Primary Target IC<sub>50</sub>100 nM
      Purity≥98% by HPLC
      Physicochemical Information
      Cell permeableN
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      RTECSQI9295900
      Safety Information
      R PhraseR: 45-46

      May cause cancer.
      May cause heritable genetic damage.
      S PhraseS: 36/37-45-53-22-28

      Wear suitable protective clothing and gloves.
      In case of accident or if you feel unwell, seek medical advice immediately (show the label where possible).
      Avoid exposure - obtain special instructions before use.
      Do not breathe dust.
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Carcinogenic / Teratogenic
      Storage +15°C to +30°C
      Protect from Light Protect from light
      Hygroscopic Hygroscopic
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, refrigerate (4°C). Stock solutions are stable for up to 1 month at 4°C. Under acidic conditions doxorubicin is converted to a water-insoluble adriamycinone and a water soluble reducing sugar, daunosamine.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Bestellnummer GTIN
      324380 0

      Documentation

      Doxorubicin, Hydrochloride - CAS 25316-40-9 - Calbiochem SDB

      Titel

      Sicherheitsdatenblatt (SDB) 

      Doxorubicin, Hydrochloride - CAS 25316-40-9 - Calbiochem Analysenzertifikate

      TitelChargennummer
      324380

      Literatur

      Übersicht
      A'Hern, R.P., and Gore, M.E. 1995. J. Clin. Oncol. 13, 726.
      Nooter, K., et al. 1995. Br. J. Cancer 71, 556.
      Noviello, E., et al. 1994. Mutat. Res. 311, 21.
      Anderson, R.D., et al. 1993. Mutat. Res. 294, 215.
      Hershko, C., et al. 1993. J. Lab. Clin. Med. 122, 245.
      Jongmans, W., et al. 1993. Mutat. Res. 294, 207.
      O'Shaughnessy, J.A., and Cowan, K.H. 1993. J. Am. Med. Assoc. 270, 2089.
      Theyer, G., et al. 1993. J. Urol. 150, 1544.
      Tritton, T.R., and Yee, G. 1982. Science 217, 248.

      Broschüre

      Titel
      Tools and Tips for Analyzing Apoptosis
      Datenblatt

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision22-May-2018 JSW
      SynonymsAdriamycin, 14-Hydroxydaunomycin, HCl
      DescriptionAn anti-tumor antibiotic and a highly effective myotoxin that inhibits topoisomerase II (IC50 = 100 nM). Binds to nucleic acids, presumably by specific intercalation into the DNA double helix, inhibiting nucleic acid synthesis. Cytotoxicity seems to be due to its ability to intercalate with DNA, interact with plasma membranes, and take part in oxidation-reduction reactions. Induces apoptosis in rhabdomyosarcoma cell lines.
      FormOrange to red powder
      CAS number25316-40-9
      RTECSQI9295900
      Chemical formulaC₂₇H₂₉NO₁₁ · HCl
      Structure formulaStructure formula
      Purity≥98% by HPLC
      SolubilityH₂O (10 mg/ml)
      Storage Protect from light
      +15°C to +30°C
      Hygroscopic
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, refrigerate (4°C). Stock solutions are stable for up to 1 month at 4°C. Under acidic conditions doxorubicin is converted to a water-insoluble adriamycinone and a water soluble reducing sugar, daunosamine.
      Toxicity Carcinogenic / Teratogenic
      Merck USA index14, 3439
      ReferencesA'Hern, R.P., and Gore, M.E. 1995. J. Clin. Oncol. 13, 726.
      Nooter, K., et al. 1995. Br. J. Cancer 71, 556.
      Noviello, E., et al. 1994. Mutat. Res. 311, 21.
      Anderson, R.D., et al. 1993. Mutat. Res. 294, 215.
      Hershko, C., et al. 1993. J. Lab. Clin. Med. 122, 245.
      Jongmans, W., et al. 1993. Mutat. Res. 294, 207.
      O'Shaughnessy, J.A., and Cowan, K.H. 1993. J. Am. Med. Assoc. 270, 2089.
      Theyer, G., et al. 1993. J. Urol. 150, 1544.
      Tritton, T.R., and Yee, G. 1982. Science 217, 248.